Erste Asset Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Erste Asset Management’s Portfolio CERE Stock Details CERE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-40,000	Closed	-$1.62M	–	575
2024 Q2	$1.62M	Hold	40,000	–	–	0.02%	326
2024 Q1	$1.7M	Hold	40,000	–	–	0.02%	318
2023 Q4	$1.7M	Buy	+40,000	New	+$1.15M	0.02%	308

Other funds holding CERE

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Erste Asset Management's CERE Position: Q3 2024 in Review

Erste Asset Management sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 40,000 shares — an estimated $1.62M sold.

Erste Asset Management first reported a position in CERE in Q4 2023 and held it in 3 quarters. The position peaked at $1.7M in Q4 2023. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

Erste Asset Management reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Erste Asset Management sold 40,000 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $1.62M.
Erste Asset Management first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
Erste Asset Management's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $1.7M in Q4 2023.
2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Erste Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.